CTRI/2012/06/002717招募中2 期
A Phase 2 randomized study to compare short course palliative Radiotherapy with short course concurrent palliative Chemotherapy plus radiotherapy in advanced and unresectable head and neck cancer .
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •A Biopsy proven Squamous cell carcinoma of the Head and Neck region.
- •B ECOG Performance Status of 1/2/3.
- •C T4b and /or N3 TUMOUR that had been unanimously defined as inoperable and incurable by multidisciplinary team members.
- •D Sites â??oral cavity, oropharynx, hypopharynx.
排除标准
- •A Patients with ECOG PS 4
- •B Non-squamous histology.
- •C H/o previous malignancy at same or other site.
- •D Patients who has received Radiotherapy or Chemotherapy in the past either from IRCH or from other centre.
研究者
相似试验
进行中（未招募）
1 期
A phase II trial of short-course versus long-course pre-operative chemotherapy with mFOLFIRINOX or PAXG regimen for stage I-III pancreatic ductal adenocarcinoma (PDACPatients with pancreatic ductal adenocarcinomaMedDRA version: 21.0Level: LLTClassification code 10033602Term: Pancreatic adenocarcinoma resectableSystem Organ Class: 100000004864EUCTR2020-003080-26-ITFONDAZIONE GISCAD (GRUPPO ITALIANO PER LO STUDIO DEI CARCINOMI DELL'APPARATO DIGERENTE)261
已完成
2 期
Oral drug therapy as palliative chemotherapy in Head and Neck cancersCTRI/2014/07/004791Tata Memorial Hospital110
招募中
2 期
A randomized controlled phase 2 trial comparing the safety and usefulness of robot-assisted esophagectomy and thoracoscopicJPRN-jRCT1040220153Takeuchi Hiroya90
已完成
2 期
A randomized controlled Phase II study comparing TS-1 alone with CDDP+TS-1 as postoperative adjuvant chemotherapy in non-small-cell-lung-cancer ; translational research of the chemotherapy effect prediction factoron Small Cell Lung CancerJPRN-UMIN000001658West Japan Oncology Group200
进行中（未招募）
不适用
A randomised phase II study evaluating two schedules of the 21-day regimen of Gemcitabine and Carboplatin in advanced NSCLCon-small cell lung cancerEUCTR2006-000744-17-BEniversity Hospital Ghent64